Menstruation
Pennsylvania Poised to be Center of State Court Yaz(R) Yasmin(R) Ocella(R) Birth Control Litigation
Published in Women's Health Law Weekly, October 4th, 2009
The lawsuits allege that Yaz® and Yasmin® have risks beyond those of traditional birth control pills, because they contain DRSP (drospirenone), and that Bayer over-promoted the drug without disclosing risks. Bayer was warned by the FDA, in the fall of 2008, that Bayer's television ads were misleading and were not disclosing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Appendicitis
Researchers from University of British Columbia report on findings in appendicitis - Breast Cancer
Pennsylvania Breast Cancer Coalition Hosts Annual Conference - Breast Cancer Survivor Coalition for Advancement, Reform and Equity Because we Care
Breast Cancer Survivors Praise House Committee Action as Vital to Health Care Reform - Gender Studies
Researchers from University of Cincinnati publish findings in gender studies - Ovarian Cancer
Medical Malpractice Victim Helps Uphold Constitutional Rights of Patients in Washington State Supreme Court Decision, Perey Law Announces - PeriGen, Inc.
Society for Maternal-Fetal Medicine Appoints New Executive Vice President: Dan O'Keeffe, M.D., F.A.C.O.G. - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
